NCT06048718 2026-03-10
TUXEDO-4
MedSIR
Phase 2 Active not recruiting
Clinical Trials
4 trialsNCT04494425 2026-03-04
DB-06
AstraZeneca
Phase 3 Active not recruiting
NCT04294628 2026-02-27
Testing the Biological Effects of DS-8201a on Patients With Advanced Cancer
National Cancer Institute (NCI)
Phase 1 Active not recruiting
NCT05113251 2026-02-23
Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast Cancer
AstraZeneca
Phase 3 Active not recruiting